Trough levels of dalbavancin during long-term treatment of prosthetic joint infections
Therapeutic drug monitoring during long-term dalbavancin treatment is recommended to avoid the risk of accumulation and unnecessarily high trough levels. In many cases, such monitoring can allow the dosing interval to be extended.
Authors
- Bo Söderquist (ORCID: https://orcid.org/0000-0001-5939-2932)
- Samira Salihović (ORCID: https://orcid.org/0000-0001-5752-4196)
- M. Møller
Institutions
- Örebro University (SE)
Publication Details
- Journal
- Infectious Diseases
- Published
- 2025-05-04
- DOI
- https://doi.org/10.1080/23744235.2025.2499144
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00